Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

ATM T328-p
AurB T45-p
EEF2K T129-p
EGFR Y148-p
ERK1 S37-p
ERK2 S37-p
GSK3B T328-p
NPM-ALK Y105-p
Pim2 T454-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Akt1 S37-p , S97-p , S202-p
AurB T45-p
EEF2K T129-p
EGFR Y148-p
ERK2 S37-p
GSK3B T328-p
NPM-ALK Y105-p
Pim2 T454-p
Phosphatases, in vitro:
CDC25A S37-p
Regulatory protein:
BRAF T45-p
CSFR Y105-p
ECM1 S37-p
EGFR T45-p , Y105-p , Y148-p , Y175-p , Y390-p
HK2 Y105-p
HSP90A T328-p
KRas T45-p
Treatment:
A484954 T129-p
anti-CD28 Y148-p
anti-CD3 Y148-p
AP20187 Y105-p
ascorbic_acid S37-p
ATP T328-p
AZD1152 T45-p
crizotinib Y105-p
doxycycline T45-p
EGF S37-p , S362-p , T405-gl , S406-gl
erlotinib Y105-p
glucose K305-ac
H2O2 T328-p
IGF-1 S202-p
ischemia S6-p
KU-55933 T328-p
metastatic potential S37-p
MG132 K89-ub
ML-7 T45-p
MLN8054 S222-p
nicotinamide K305-ac
nocodazole S37-p
PHA-665752 Y105-p
PUGNAc S37-p , T405-gl , S406-gl
siRNA T129-p , K305-ac , T454-p
trichostatin_A K305-ac
U0126 S37-p , Y148-p
vorinostat K115-ub
WZ4002 Y105-p
Y27632 T45-p